Table 5.
Predictors of cholangitis.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
Age | 1.048 | 0.990-1.109 | 0.104 | |||
Gender | ||||||
Male | 1 | |||||
Female | 0.753 | 0.300-1.888 | 0.545 | |||
Tumor stage | ||||||
III | 1 | |||||
IV | 2.212 | 0.859-5.697 | 0.100 | |||
ECOG PS | 0.664 | 0.396-1.114 | 0.121 | |||
Bismuth type | ||||||
II | 1 | |||||
III | 1.091 | 0.415-2.868 | 0.860 | |||
IV | 0.477 | 0.095-2.395 | 0.369 | |||
TBIL | 1.000 | 0.996-1.004 | 0.994 | |||
Ca19-9 | 1.000 | 0.999-1.000 | 0.236 | |||
Stent insertion | ||||||
Unilateral | 1 | |||||
Bilateral | 1.387 | 0.553-3.477 | 0.486 | |||
Post-operative chemotherapy | ||||||
No | 1 | |||||
Yes | 0.772 | 0.298-2.001 | 0.594 |
ECOG PS, Eastern Cooperative Oncology Group performance status; TBIL, total bilirubin.